British Journal of Haematology

Hair-on-end appearance in radiograph of skull and facial bones in a case of beta thalassaemia
pp. 807-807(1)
Authors: Basu, Sriparna; Kumar, Ashok

Multiple splenic calcifications
pp. 808-808(1)
Authors: Fyfe, Andrew J.; Gallipoli, Paolo

Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?
pp. 809-817(9)
Authors: Wardrop, Douglas; Steensma, David P.

Rediscovering alemtuzumab: current and emerging therapeutic roles
pp. 818-831(14)
Authors: Gribben, John G.; Hallek, Michael

How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?
pp. 832-837(6)
Authors: Siragusa, Sergio; Caramazza, Domenica; Malato, Alessandra

Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia
pp. 838-847(10)
Authors: Paulsson, Kajsa; An, Qian; Moorman, Anthony V.; Parker, Helen; Molloy, Gael; Davies, Teresa; Griffiths, Mike; Ross, Fiona M.; Irving, Julie; Harrison, Christine J.; Young, Bryan D.; Strefford, Jon C.

The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia
pp. 848-855(8)
Authors: Lapalombella, Rosa; Gowda, Aruna; Joshi, Trupti; Mehter, Najma; Cheney, Carolyn; Lehman, Amy; Chen, Ching-Shih; Johnson, Amy J.; Caligiuri, Michael A.; Tridandapani, Susheela; Muthusamy, Natarajan; Byrd, John C.

Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1)
pp. 856-864(9)
Authors: Sánchez-Vega, Beatriz; Gandhi, Varsha

Bis(1H-indol-2-yl)methanones are effective inhibitors of FLT3-ITD tyrosine kinase and partially overcome resistance to PKC412A in vitro
pp. 865-874(10)
Authors: Heidel, Florian; Lipka, Daniel B.; Mirea, Fian K.; Mahboobi, Siavosh; Grundler, Rebekka; Kancha, Rama K.; Duyster, Justus; Naumann, Michael; Huber, Christoph; Böhmer, Frank D.; Fischer, Thomas

The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells
pp. 875-886(12)
Authors: Baumann, Philipp; Müller, Karin; Mandl-Weber, Sonja; Leban, Johann; Doblhofer, Robert; Ammendola, Astrid; Baumgartner, Roland; Oduncu, Fuat; Schmidmaier, Ralf

Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma
pp. 887-894(8)
Authors: Popat, Rakesh; Oakervee, Heather; Williams, Catherine; Cook, Mark; Craddock, Charles; Basu, Supratik; Singer, Charles; Harding, Stephen; Foot, Nicola; Hallam, Simon; Odeh, Liz; Joel, Simon; Cavenagh, Jamie

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
pp. 895-903(9)
Authors: Richardson, Paul G.; Sonneveld, Pieter; Schuster, Michael W.; Stadtmauer, Edward A.; Facon, Thierry; Harousseau, Jean-Luc; Ben-Yehuda, Dina; Lonial, Sagar; Goldschmidt, Hartmut; Reece, Donna; Bladé, Joan; Boccadoro, Mario; Cavenagh, Jamie D.; Boral, Anthony L.; Esseltine, Dixie-Lee; Wen, Patrick Y.; Amato, Anthony A.; Anderson, Kenneth C.; San Miguel, Jesus

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones
pp. 904-908(5)
Authors: Beer, Philip A.; Jones, Amy V.; Bench, Anthony J.; Goday-Fernandez, Andrea; Boyd, Elaine M.; Vaghela, Krishna J.; Erber, Wendy N.; Odeh, Bassam; Wright, Christine; McMullin, Mary Frances; Cullis, Jonathan; Huntly, Brian J. P.; Harrison, Claire N.; Cross, Nicholas C. P.; Green, Anthony R.

Peripheral blood progenitor cell collection adverse events for childhood allogeneic donors: variables related to the collection and safety profile
pp. 909-916(8)
Authors: Sevilla, Julián; González-Vicent, Marta; Lassaletta, Alvaro; Ramírez, Manuel; Pérez-Martínez, Antonio; Madero, Luis; Díaz, Miguel Angel

Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis
pp. 917-929(13)
Authors: Jo, Aoi; Tsukimoto, Ichiro; Ishii, Eiichi; Asou, Norio; Mitani, Sachiyo; Shimada, Akira; Igarashi, Takashi; Hayashi, Yasuhide; Ichikawa, Hitoshi

Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia
pp. 930-932(3)
Authors: Gaikwad, Amos; Rye, Cassia L.; Devidas, Meenakshi; Heerema, Nyla A.; Carroll, Andrew J.; Izraeli, Shai; Plon, Sharon E.; Basso, Giuseppe; Pession, Andrea; Rabin, Karen R.

Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA
pp. 933-945(13)
Authors: Lawler, Mark; McCann, Shaun R.; Marsh, Judith C. W.; Ljungman, Per; Hows, Jill; Vandenberghe, Elisabeth; O'Riordan, Joan; Locasciulli, Anna; Socié, Gérard; Kelly, Alan; Schrezenmeier, Hubert; Marin, Pedro; Tichelli, André; Passweg, Jakob R.; Dickenson, Anne; Ryan, Jacqueline; Bacigalupo, Andrea

The protein C ω-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity
pp. 946-953(8)
Authors: Preston, Roger J. S.; Morse, Colin; Murden, Sherina L.; Brady, Sara Kate; O'Donnell, James S.; Mumford, Andrew D.

Ethnic differences in F cell levels in Jamaica: a potential tool for identifying new genetic loci controlling fetal haemoglobin
pp. 954-960(7)
Authors: Creary, Lisa E.; McKenzie, Colin A.; Menzel, Stephan; Hanchard, Neil A.; Taylor, Veronica; Hambleton, Ian; Spector, Tim D.; Forrester, Terrence E.; Thein, Swee Lay

Upregulated MCL1 mRNA expression in multiple myeloma lacks association with survival
pp. 961-963(3)
Authors: Mylin, Anne K.; Rasmussen, Thomas; Lodahl, Marianne; Dahl, Inger Marie; Knudsen, Lene M.

AL amyloidosis and progression to multiple myeloma with gain(1q)
pp. 963-964(2)
Authors: Hoffman, James; Jhanwar, Suresh; Comenzo, Raymond L.

Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms
pp. 965-967(3)
Authors: Za, Tommaso; Fiorini, Alessia; Rossi, Elena; Ciminello, Angela; Chiusolo, Patrizia; Leone, Giuseppe; De Stefano, Valerio

Is rituximab effective in acquired von Willebrand syndrome?
pp. 967-968(2)
Authors: Mazoyer, Elisabeth; Fain, Olivier; Dhote, Robin; Laurian, Yves

From a medical mistake to a clinical warning: the case of HBV mutant virus reactivation in haematological patients
pp. 969-970(2)
Authors: Gabriele, Zoppoli; Bianca, Bruzzone; Patrizia, Caligiuri; Antonino, Picciotto; Enrico, Balleari; Andrea, Bruzzone; Giancarlo, Icardi; Riccardo, Ghio

Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?
pp. 970-972(3)
Authors: Giebel, Sebastian; Krawczyk-Kulis, Malgorzata; Kyrcz-Krzemien, Slawomira; Haus, Olga; Jagoda, Krystyna; Piatkowska-Jakubas, Beata; Paluszewska, Monika; Seferynska, Ilona; Chrobok, Aleksandra; Stella-Holowiecka, Beata; Kielbinski, Marek; Holowiecki, Jerzy